CareersInvestor RelationsPress RoomCOVID-19
Login
  1. Home
  2. Laboratory Diagnostics
  3. Tested. To do more.
  4. Clinical Excellence

Clinical excellence for better outcomes

We’re leading with high sensitivity, optimal precision, and world-class Sigma values, including some of the industry’s only CDC-certified assays.

Accurate test results

Accurate test results…

Accurate results enable you to assess results with a high level of confidence.

doctor and lab tech

…at the right time…

Faster test results help provide you with the critical information needed for patient care.

immunoassy and chemistry assay menu

…from an expansive menu

Our immunoassy and chemistry assay menu comprises over 200 tests and counting.1

Our industry-leading assays

We’re leading the industry with our assays, including true high-sensitivity troponin, B•R•A•H•M•S Procalcitonin, key infectious diseases, drugs of abuse, and Enhanced Liver Fibrosis.

person with hand on chest

High-sensitivity Troponin I

Provides precise results across over 90% of the low end of detection. Enables a clearer clinical assessment with sex specific cutoffs, meeting the guidelines for a true high sensitivity troponin assay for both men and women. Shows high tolerance to common interferents.3

B•R•A•H•M•S Procalcitonin

B•R•A•H•M•S Procalcitonin

Proven B.R.A.H.M.S PCT technology brings advantages of lowend sensitivity, optimal precision at the decision points, workflow excellence, and no biotin interference for better patient care.4

Infectious diseases

Infectious diseases

ID assays include SARS-Cov-2 Serology5, Hepatitis B, Syphilis, and a 4th-generation CHIV assay. They provide high sensitivity and improved specificity for the highest level of confidence and early detection.

Drugs of abuse

Drugs of abuse

Eight-assay drugs-of-abuse menu combines proven technology and workflow excellence on one automated platform. Includes Fentanyl II, Tramadol, Buprenorphine, Oxycodone, and more.

ELF image Blue Liver

Enhanced Liver Fibrosis (ELF)

The ELF™ Test is a noninvasive blood test that measures three direct markers of fibrosis. In conjunction with other laboratory and clinical findings, the ELF test can be used in patients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH) to assess the likelihood of progression to cirrhosis and liver-related clinical events.6

1

Assay availability varies by country.

2

Strengthening Clinical Laboratories [Internet]. CDC Division of Laboratory Systems (DLS); [updated 2018 Nov 15; cited 2021 Sep 10]. Available from: https://www.cdc.gov/csels/dls/strengthening-clinical-labs.html

3

Siemens Healthineers Atellica IM High-Sensitivity Troponin I IFU 11200498_EN Rev. 06, 2019-06

4

Schuetz P, et al. Arch Intern Med. 2011 Aug 8;171(15):1322-31.

5

These tests have not been FDA cleared or approved. They have been authorized by FDA under an EUA for use by authorized laboratories. The serology (“antibody”) test has been authorized only for detecting the presence of antibodies against SARS-CoV-2, not for any other viruses or pathogens. These tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. Product availability may vary from country to country and is subject to varying regulatory requirements.

6

The products/features mentioned herein are not commercially available in all countries. Their future availability cannot be guaranteed.

Subscription Button Icon

Subscribe to news from Siemens Healthineers USA

Be the first to know about our events, training, and news